Stock Ratings / Health Care / USNA / dividends

ACB (58) CGC (51) SNDL (61) GLAS (25) ⌘ Pro Terminal →

USANA Health Sciences Inc. (USNA) Dividend Safety Gauge & 10-Year DRIP Compounder

$14.34 -1.91% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

USANA Health Sciences Inc. (USNA) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C- • HOLD / WATCH Cap $265.0M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C+

Each axis scored 0–20

12M PRICE TARGET CONE+1.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for USNA)Realized 20D OHLCV Swing Band: ±8.9%

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.4% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $18,596

Est. Year-10 Shareholder Yield: $335/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.3K

Yr 2

$12.0K

Yr 3

$12.8K

Yr 4

$13.6K

Yr 5

$14.5K

Yr 6

$15.4K

Yr 7

$16.4K

Yr 8

$17.5K

Yr 9

$18.6K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in USNA & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on USNA and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

USNA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -24.72%🛡️ HOLDING TREND SUPPORT

2026-10-30O $14.27H $14.47L $14.15C $14.34VOL 141.0K

RES: $26.69SUP: $13.70SMA50: $14.55SMA200: $18.11

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

USNA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 USNA Butterfly Map → + Track USNA →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

18.3%/yr Implied 5Y Growth

vs. +8.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on USNA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for USNA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for USNA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (USNA)

Health Care Rank #193 of 1016 ⚔️ ACB vs USNA Full Matrix →

1. Head-to-Head Health Care Peer Comparison (USNA vs. ACB, CGC, SNDL, GLAS)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, USANA Health Sciences Inc. (USNA) ranks #193 by composite RQD confidence (61/100, grade C-) and #535 by equity capitalization ($265.0M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. USNA currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
USNA ACTIVE USANA Health Sciences Inc.	C-	61/100	24.6x	78.3%	7.9%	-1.91%	$265.0M	Benchmark Subject
ACB Aurora Cannabis Inc.	D+	58/100	—	—	—	0.00%	$252.8M	/acb-vs-usna →
CGC Canopy Growth Corporation	D	51/100	—	—	—	+0.46%	$285.6M	/cgc-vs-usna →
SNDL SNDL Inc.	C-	61/100	—	—	—	+0.78%	$316.3M	/sndl-vs-usna →
GLAS Glass House Brands Inc. Subordinate Voting Shares	E	25/100	—	42.3%	-9.2%	+1.33%	$200.6M	/glas-vs-usna →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-01-03 • CIK 0000896264

In its most recent audited fiscal period (FY2025, filed 2026-01-03), USANA Health Sciences Inc. (USNA) reported GAAP revenue of $925.3M (+8.3% vs. FY2024 revenue of $854.5M , and +0.5% cumulative change since FY2023) , GAAP net income of $10.8M, operating cash flow of $22.3M, and free cash flow of $8.5M (-83.3% YoY). On the balance sheet, USNA closed FY2025 with $742.9M in total assets against $0 in total debt (Altman Z-Score: 3.56, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-01-03	$925.3M	$10.8M	$22.3M	$8.5M	$742.9M	—
FY2024 (FY)	2024-12-28	$854.5M	$42.0M	$61.0M	$50.9M	$748.2M	—
FY2023 (FY)	2023-12-30	$921.0M	$63.8M	$70.6M	$70.6M	—	—

3. USNA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is USNA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, USANA Health Sciences Inc. (NYSE: USNA) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $14.34 (-1.91% 1D, market cap $265.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, USNA ranks #193 in composite RQD confidence.

How does USNA compare to ACB and CGC in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), USNA carries a Roarable C- (61/100 RQD), trailing P/E of 24.6x, gross margin of 78.3%, and ROIC of 7.9%. By comparison, ACB (Aurora Cannabis Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $252.8M) and CGC (Canopy Growth Corporation) posts a D grade (51/100 RQD, P/E N/A, ROIC —, cap $285.6M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for USNA?

Per USNA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0000896264), USANA Health Sciences Inc. generated $925.3M in revenue (+8.3% YoY), $10.8M in net income, and $8.5M in free cash flow against $742.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is USNA trading relative to its 50-day, 200-day, and 52-week technical levels?

USNA last traded at $14.34 (-1.91% on volume of 129,592 shares), positioning the stock -1.44% below its 50-day simple moving average ($14.55) and -20.82% below its 200-day simple moving average ($18.11). Across its 52-week range of $12.57 to $23.59, USNA sits at the 16.1% percentile with a 14-day RSI of 45.3 (NEUTRAL RANGE) and an implied next-earnings move of ±8.9% ($13.06 to $15.62).

USNA Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does USNA pay a dividend and is it safe?

USANA Health Sciences Inc. (USNA) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: USNA RQD Cockpit USNA 12M Forecast USNA Earnings & Move USNA Dividends & DRIP USNA Insiders & 13F USNA Whale Options USNA Profit Sankey USNA News & Why